Defibrillator Market to Witness 5.1% of CAGR by 2027 – The Insight Partners
The Defibrillator market is projected to reach US$ 14,876.95 million by 2028 from US$ 10,478.31 million in 2021. It is estimated to grow at a CAGR of 5.1% % from 2021 to 2028. Several factors, such as the increasing prevalence of cardiovascular disorders along with surge in training and awareness programs on cardiopulmonary resuscitation and automated external defibrillators. However, cost and performance issues related to implantable and automated external defibrillators is expected to hamper market growth.
Defibrillators are devices that give a high energy shock to the heart of a patient who is in cardiac arrest. The increasing prevalence and incidence of cardiovascular diseases (CVDs) has led to the risk of cardiac dysrhythmias, specifically ventricular fibrillation (VF) and non-perfusing ventricular tachycardia (VT) among patients which can be treated through the use of defibrillators. A defibrillator can be external or implantable. An external defibrillator comes in various types, including manual, automated, and wearable. Whereas, an implantable defibrillator is usually implanted on or inside a patient and can be transvenous implantable cardioverter defibrillator (ICD) or subcutaneous ICD.
Request PDF Sample Copy of Report: https://www.theinsightpartners.com/sample/TIPRE00004564/
Key Players Influencing the Market
- Medtronic plc
- Abbott Laboratories
- Boston Scientific Corp.
- Koninklijke Philips NV
- Biotronik, Inc.
- Zoll Medical Corp.
- Nihon Kohden Corp.
- Progetti srl
- CU Medical Systems, Inc.
- Shenzhen Mindray Biomedical Electronics Co., Ltd.
Based on the product type, the defibrillator market is segmented into Implantable cardioverter defibrillator, and External. The implantable cardioverter defibrillator segment is sub segmented into, transverse ICD and subcutaneous ICD. Moreover, the external segmented is further sub segmented as, Fully Automated External Defibrillators, manual, wearable. The Implantable cardioverter defibrillator segment is expected to hold the largest share of 68.80% of the defibrillator market in 2021. Based on the end user, the defibrillator market has been segmented into Hospitals and Clinics, Prehospital Care, Public Access, Home Care Settings, and Alternate Care Facilities. The Hospitals and Clinics segment is likely to account for a larger market share in 2021. However, the prehospital care segment is expected to register a higher CAGR in the market during the forecast period.
National Center for Chronic Disease Prevention and Health Promotion, World Health Organization, Australian Bureau of Statistics are among the primary and secondary sources referred to while preparing the defibrillator market report.
Table of Content – Major Key Points
1 Scope of the Report
2 Executive Summary
3 Global defibrillator by Company
4 World Historic Review for defibrillator by Geographic Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Manufacturing Cost Structure Analysis
11 Marketing, Distributors and Customer
12 World Forecast Review for defibrillator by Geographic Region
13 Key Players Analysis
14 Research Findings and Conclusion
Buy Single User PDF Report@ https://www.theinsightpartners.com/buy/TIPRE00004564/
Answers that the report acknowledges:
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
Our Most Selling Reports
EEG Machines Market Forecast to 2028
Encapsulation Market Forecast to 2028
Blockchain Market Growth 2022-2028
Contact Us:
533, 5th Floor, Amanora Chambers,
Amanora Township, East Block,
Kharadi Road, Hadapsar, Pune-
